M12 Drug Interaction Studies
M12 EWG Drug Interaction Studies
This topic was endorsed by the ICH Assembly in June 2018.
The M12 EWG is working on the development of a new M12 Guideline on “Drug Interaction Studies” with a view to providing a consistent approach in designing, conducting, and interpreting Drug-drug interactions studies during the development of a therapeutic product.
Guidelines (Click the links below for complete guidelines)
Endorsed Documents (Click the links below for complete guidelines)
*These Guidelines Belongs to ICH website.